Skip to main content
Erschienen in: Osteoporosis International 11/2016

11.06.2016 | Review

Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis

verfasst von: P. Lucato, C. Trevisan, B. Stubbs, B. M. Zanforlini, M. Solmi, C. Luchini, G. Girotti, S. Pizzato, E. Manzato, G. Sergi, S. Giannini, M. Fusaro, N. Veronese

Erschienen in: Osteoporosis International | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Summary

Our meta-analysis demonstrates that people with nephrolithiasis have decreased bone mineral density, an increased odds of osteoporosis, and potentially an elevated risk of fractures.

Introduction

People with nephrolithiasis might be at risk of reduced bone mineral density (BMD) and fractures, but the data is equivocal. We conducted a meta-analysis to investigate if patients with nephrolithiasis have worse bone health outcomes (BMD), osteoporosis, and fractures versus healthy controls (HCs).

Methods

Two investigators searched major databases for articles reporting BMD (expressed as g/cm2 or a T- or Z-score), osteoporosis or fractures in a sample of people with nephrolithiasis, and HCs. Standardized mean differences (SMDs), 95 % confidence intervals (CIs) were calculated for BMD parameters; in addition odds (ORs) for case-control and adjusted hazard ratios (HRs) in longitudinal studies for categorical variables were calculated.

Results

From 1816 initial hits, 28 studies were included. A meta-analysis of case-control studies including 1595 patients with nephrolithiasis (mean age 41.1 years) versus 3402 HCs (mean age 40.2 years) was conducted. Patients with nephrolithiasis showed significant lower T-scores values for the spine (seven studies; SMD = −0.69; 95 % CI = −0.86 to −0.52; I 2 = 0 %), total hip (seven studies; SMD = −0.82; 95 % CI = −1.11 to −0.52; I 2 = 72 %), and femoral neck (six studies; SMD = −0.67; 95 % CI = −−1.00 to −0.34; I 2 = 69 %). A meta-analysis of the case-controlled studies suggests that people with nephrolithiasis are at increased risk of fractures (OR = 1.15, 95 % CI = 1.12–1.17, p < 0.0001, studies = 4), while the risk of fractures in two longitudinal studies demonstrated trend level significance (HR = 1.31, 95 % CI = 0.95–1.62). People with nephrolithiasis were four times more likely to have osteoporosis than HCs (OR = 4.12, p < 0.0001).

Conclusions

Nephrolithiasis is associated with lower BMD, an increased risk of osteoporosis, and possibly, fractures. Future screening/preventative interventions targeting bone health might be indicated.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Lawoyin S, Sismilich S, Browne R, Pak CY (1979) Bone mineral content in patients with calcium urolithiasis. Metabolism 28:1250–4CrossRefPubMed Lawoyin S, Sismilich S, Browne R, Pak CY (1979) Bone mineral content in patients with calcium urolithiasis. Metabolism 28:1250–4CrossRefPubMed
6.
8.
Zurück zum Zitat Giannini S, Nobile M, Dalle Carbonare L et al (2003) Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 149:209–13CrossRefPubMed Giannini S, Nobile M, Dalle Carbonare L et al (2003) Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 149:209–13CrossRefPubMed
10.
Zurück zum Zitat Thorleifsson G, Holm H, Edvardsson V et al (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41:926–30. doi:10.1038/ng.404 CrossRefPubMed Thorleifsson G, Holm H, Edvardsson V et al (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41:926–30. doi:10.​1038/​ng.​404 CrossRefPubMed
11.
Zurück zum Zitat Rebsamen MC, Sun J, Norman AW, Liao JK (2002) 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17–24CrossRefPubMed Rebsamen MC, Sun J, Norman AW, Liao JK (2002) 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17–24CrossRefPubMed
13.
Zurück zum Zitat Fuss M, Pepersack T, Van Geel J et al (1990) Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 46:9–13CrossRefPubMed Fuss M, Pepersack T, Van Geel J et al (1990) Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 46:9–13CrossRefPubMed
14.
Zurück zum Zitat Trinchieri A, Nespoli R, Ostini F et al (1998) A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 159:654–7CrossRefPubMed Trinchieri A, Nespoli R, Ostini F et al (1998) A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 159:654–7CrossRefPubMed
15.
17.
Zurück zum Zitat IQ solutions I bone mass measurement: what the numbers mean IQ solutions I bone mass measurement: what the numbers mean
21.
Zurück zum Zitat Sella S, Cattelan C, Realdi G, Giannini S (2008) Bone disease in primary hypercalciuria. Clin Cases Miner Bone Metab 5:118–26PubMedPubMedCentral Sella S, Cattelan C, Realdi G, Giannini S (2008) Bone disease in primary hypercalciuria. Clin Cases Miner Bone Metab 5:118–26PubMedPubMedCentral
30.
32.
Zurück zum Zitat Denburg MR, Leonard MB, Haynes K et al (2014) Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network. Clin J Am Soc Nephrol 1–8. doi: 10.2215/CJN.04340514 Denburg MR, Leonard MB, Haynes K et al (2014) Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network. Clin J Am Soc Nephrol 1–8. doi: 10.​2215/​CJN.​04340514
34.
Zurück zum Zitat Ghazali A, Fuentès V, Desaint C et al (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32–8PubMed Ghazali A, Fuentès V, Desaint C et al (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32–8PubMed
35.
Zurück zum Zitat Guerra, Angela Nouvenne, Antonio Pedrazzoni, Michele Meschi T (2009) Guerra, 2009 abstract.pdf. In: Eff. body Compos. bone density Heal. Women with idiopathic calcium nephrolithiasis. p 81 Guerra, Angela Nouvenne, Antonio Pedrazzoni, Michele Meschi T (2009) Guerra, 2009 abstract.pdf. In: Eff. body Compos. bone density Heal. Women with idiopathic calcium nephrolithiasis. p 81
36.
Zurück zum Zitat Heilberg IP, Martini LA, Szejnfeld VL et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–82PubMed Heilberg IP, Martini LA, Szejnfeld VL et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–82PubMed
38.
Zurück zum Zitat Jaeger P, Lippuner K, Casez JP et al (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. 9 Jaeger P, Lippuner K, Casez JP et al (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. 9
39.
Zurück zum Zitat Kaste SC, Thomas NA, Rai SN et al (2009) Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK 23:104–108. doi:10.1038/leu.2008.269 CrossRef Kaste SC, Thomas NA, Rai SN et al (2009) Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leuk Off J Leuk Soc Am Leuk Res Fund UK 23:104–108. doi:10.​1038/​leu.​2008.​269 CrossRef
41.
Zurück zum Zitat Mete U, Garg PR, Prakash M, Dutta P (2015) Pd4-02 should bone mineral density (BMD) be included in the metabolic evaluation of young adults with calcium kidney stone disease?: a prospective study. J Urol 193:e87. doi:10.1016/j.juro.2015.02.314 CrossRef Mete U, Garg PR, Prakash M, Dutta P (2015) Pd4-02 should bone mineral density (BMD) be included in the metabolic evaluation of young adults with calcium kidney stone disease?: a prospective study. J Urol 193:e87. doi:10.​1016/​j.​juro.​2015.​02.​314 CrossRef
42.
Zurück zum Zitat Moyano MJ, Tejada MJG De, Lozano RG et al (2007) Alteraciones en el metabolismo mineral óseo en pacientes con urolitiasis de repetición y polimorfismos del gen del receptor de la vitamina D . Resultados preliminares Moyano MJ, Tejada MJG De, Lozano RG et al (2007) Alteraciones en el metabolismo mineral óseo en pacientes con urolitiasis de repetición y polimorfismos del gen del receptor de la vitamina D . Resultados preliminares
43.
Zurück zum Zitat Pricop C (2014) Particularities of bone metabolism and calcium regulators in a group of young males with idiopathic hypercalciuria and relapsing kidney lithiasis. Acta Endocrinol 10:220–227. doi:10.4183/aeb.2014.220 Pricop C (2014) Particularities of bone metabolism and calcium regulators in a group of young males with idiopathic hypercalciuria and relapsing kidney lithiasis. Acta Endocrinol 10:220–227. doi:10.​4183/​aeb.​2014.​220
44.
Zurück zum Zitat Weisinger JR, Alonzo E, Bellorin-Font E et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250CrossRefPubMed Weisinger JR, Alonzo E, Bellorin-Font E et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250CrossRefPubMed
46.
Zurück zum Zitat Zanchetta JR, Rodriguez G, Negri AL et al (1996) Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 73:557–560PubMed Zanchetta JR, Rodriguez G, Negri AL et al (1996) Bone mineral density in patients with hypercalciuric nephrolithiasis. Nephron 73:557–560PubMed
47.
Zurück zum Zitat Borowy P, Czerwinski E, Gorna A (2011) BMD in postmenopausal women with nephrolithiasis: 5-10-year observations. Osteoporos Int 22(Suppl 1):S218. doi:10.1007/s00198-011-1567-4 Borowy P, Czerwinski E, Gorna A (2011) BMD in postmenopausal women with nephrolithiasis: 5-10-year observations. Osteoporos Int 22(Suppl 1):S218. doi:10.​1007/​s00198-011-1567-4
48.
Zurück zum Zitat Tasca A, Cacciola A, Ferrarese P et al (2002) Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 59:865–9, discussion 869CrossRefPubMed Tasca A, Cacciola A, Ferrarese P et al (2002) Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 59:865–9, discussion 869CrossRefPubMed
49.
Zurück zum Zitat Cvijetic S, Füredi-milhofer H, Babic-ivancic V, Tucak A (2002) Bone mineral density loss in patients with urolithiasis: a follow-up study. 33:152–157 Cvijetic S, Füredi-milhofer H, Babic-ivancic V, Tucak A (2002) Bone mineral density loss in patients with urolithiasis: a follow-up study. 33:152–157
54.
Zurück zum Zitat Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S et al (2012) Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density. Singap Med J 53:808–13 Arrabal-Polo MA, Arrabal-Martin M, Arias-Santiago S et al (2012) Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density. Singap Med J 53:808–13
56.
Zurück zum Zitat Tannenbaum C, Clark J, Schwartzman K et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–7. doi:10.1210/jc.2002-020275 CrossRefPubMed Tannenbaum C, Clark J, Schwartzman K et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–7. doi:10.​1210/​jc.​2002-020275 CrossRefPubMed
57.
Zurück zum Zitat Eller-Vainicher C, Cairoli E, Zhukouskaya VV et al (2013) Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture. Eur J Endocrinol 169:225–37. doi:10.1530/EJE-13-0102 CrossRefPubMed Eller-Vainicher C, Cairoli E, Zhukouskaya VV et al (2013) Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture. Eur J Endocrinol 169:225–37. doi:10.​1530/​EJE-13-0102 CrossRefPubMed
58.
Zurück zum Zitat Bordier P, Ryckewart A, Gueris J, Rasmussen H (1977) On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 63:398–409CrossRefPubMed Bordier P, Ryckewart A, Gueris J, Rasmussen H (1977) On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 63:398–409CrossRefPubMed
59.
Zurück zum Zitat Vezzoli G, Rubinacci A, Bianchin C et al (2003) Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 42:1177–83CrossRefPubMed Vezzoli G, Rubinacci A, Bianchin C et al (2003) Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 42:1177–83CrossRefPubMed
60.
Zurück zum Zitat Vezzoli G, Arcidiacono T, Paloschi V et al (2008) Update on the genetics of nephrolithiasis. Clin Cases Miner Bone Metab 5:110–3PubMedPubMedCentral Vezzoli G, Arcidiacono T, Paloschi V et al (2008) Update on the genetics of nephrolithiasis. Clin Cases Miner Bone Metab 5:110–3PubMedPubMedCentral
61.
Zurück zum Zitat Tebben PJ, Milliner DS, Horst RL et al (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97:E423–7. doi:10.1210/jc.2011-1935 CrossRefPubMedPubMedCentral Tebben PJ, Milliner DS, Horst RL et al (2012) Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab 97:E423–7. doi:10.​1210/​jc.​2011-1935 CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Reed BY, Gitomer WL, Heller HJ et al (2002) Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–85. doi:10.1210/jcem.87.4.8300 CrossRefPubMed Reed BY, Gitomer WL, Heller HJ et al (2002) Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–85. doi:10.​1210/​jcem.​87.​4.​8300 CrossRefPubMed
64.
Zurück zum Zitat Prié D, Beck L, Friedlander G, Silve C (2004) Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization. Curr Opin Nephrol Hypertens 13:675–81CrossRefPubMed Prié D, Beck L, Friedlander G, Silve C (2004) Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization. Curr Opin Nephrol Hypertens 13:675–81CrossRefPubMed
65.
Zurück zum Zitat Tsao K-C, Wu T-L, Chang P-Y et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426–31. doi:10.1002/jcla.20215 CrossRefPubMed Tsao K-C, Wu T-L, Chang P-Y et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426–31. doi:10.​1002/​jcla.​20215 CrossRefPubMed
68.
Zurück zum Zitat Heaney RP (2008) Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr 27:519–27CrossRefPubMed Heaney RP (2008) Calcium supplementation and incident kidney stone risk: a systematic review. J Am Coll Nutr 27:519–27CrossRefPubMed
71.
Zurück zum Zitat Nouvenne A, Meschi T, Guerra A et al (2008) Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab 5:135–41PubMedPubMedCentral Nouvenne A, Meschi T, Guerra A et al (2008) Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab 5:135–41PubMedPubMedCentral
73.
Zurück zum Zitat Heaney RP, Layman DK (2008) Amount and type of protein influences bone health. Am J Clin Nutr 87:1567S–1570PubMed Heaney RP, Layman DK (2008) Amount and type of protein influences bone health. Am J Clin Nutr 87:1567S–1570PubMed
Metadaten
Titel
Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis
verfasst von
P. Lucato
C. Trevisan
B. Stubbs
B. M. Zanforlini
M. Solmi
C. Luchini
G. Girotti
S. Pizzato
E. Manzato
G. Sergi
S. Giannini
M. Fusaro
N. Veronese
Publikationsdatum
11.06.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 11/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3658-8

Weitere Artikel der Ausgabe 11/2016

Osteoporosis International 11/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.